Picture of Laboratoires Euromedis SA logo

ALEMG — Laboratoires Euromedis SA News Story

0.000.00%
fr flag iconLast trade - 00:00
HealthcareAdventurousMicro CapSuper Stock

Brief: EUROMEDIS Groupe Suspends Revenue Targets For 2020

April 22 (Reuters) - EUROMEDIS GROUPE SA  EUMD.PA :
    * EUROMEDIS: 2019 AND Q1 2020 RESULTS
    * FY CONSOLIDATED REVENUE EUR 77.1 MILLION VERSUS EUR 107.8
MILLION YEAR AGO
    * FY EBITDA LOSS EUR 0.04 MILLION VERSUS LOSS OF EUR 2.3
MILLION
YEAR AGO
    * FY NET LOSS GROUP SHARE EUR 3.8 MILLION VERSUS LOSS OF EUR
6.9
MILLION YEAR AGO
    * THE SALES TARGETS COMMUNICATED ON 13 FEBRUARY 2020 ARE NO
LONGER
VALID
    * IT IS DIFFICULT TO ASSESS THE IMPACT OF THE HEALTH CRISIS
ON
2020 CONSOLIDATED ANNUAL SALES FIGURE

Source text for Eikon:  ID:nNDL8pg3CN 
Further company coverage:  EUMD.PA 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 778 51 10;))

Recent news on Laboratoires Euromedis SA

See all news